Kim M Smith-Whitley MD

PubMed

• Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study.
  Aimee K Hildenbrand, Constance A Mara, Bridget Murphy, Anna M Hood, Yolanda Johnson
  Pediatric Blood & Cancer. 2025-05-01
• 1 citations
  The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study.
  Kemar V Prussien, Haley L Faust, Lori E Crosby, Kim Smith-Whitley, Lamia P Barakat
  Pediatric Blood & Cancer. 2024-09-01
• 1 citations
  Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.
  Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley
  Pediatric Blood & Cancer. 2024-09-01

Abstracts/Posters

• Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease
  Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies
  Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• 2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 _-Thalassemia Patient Cells: A Foundation for Potential Therapies
  Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Preclinical Evaluation of ALS20, a New and Improved Lentiviral Vector for Beta-Globinopathies
  Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Management of Sickle Cell Disease Complications Beyond Acute Chest 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Featured Topic: Sickle Cell Disease: New Drugs, Curative Approaches 
  60th American Society of Hematology Annual Meeting - 12/3/2018